TMTC1 promotes invasiveness of ovarian cancer cells through integrins β1 and β4 | Cancer Gene Therapy
The DDUP protein encoded by the DNA damage-induced CTBP1-DT lncRNA confers cisplatin resistance in ovarian cancer | Cell Death & Disease
Epidemiology of Ovarian Cancer (Chapter 1) - Cancer of the Ovary
Mode of Referral of Ovarian Cancer Patients: Does it Alter Treatment and Survival? | In Vivo
Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell - ScienceDirect
Epidemiology of ovarian cancer: a review | Cancer Biology & Medicine
Frontiers | When Is “Type I” Ovarian Cancer Not “Type I”? Indications of an Out-Dated Dichotomy
Ovarian cancer survival by stage, histotype, and pre-diagnostic lifestyle factors, in the prospective UK Million Women Study - ScienceDirect
Siomycin A induces reactive oxygen species‑mediated cytotoxicity in ovarian cancer cells
Ovarian endometriosis, a precursor of ovarian cancer: Histological aspects, gene expression and microRNA alterations (Review)
Frontiers | Systematic analysis and prediction for disease burden of ovarian cancer attributable to hyperglycemia: a comparative study between China and the world from 1990 to 2019
A Comprehensive Epithelial Tubo-Ovarian Cancer Risk Prediction Model Incorporating Genetic and Epidemiological Risk Factors | medRxiv
Epidemiology of epithelial ovarian cancer - ScienceDirect
Epidemiology of ovarian cancer: a review | Cancer Biology & Medicine
Trends and projections of ovarian cancer incidence in Hong Kong: A population‐based study - Chen - 2023 - Acta Obstetricia et Gynecologica Scandinavica - Wiley Online Library
Cancers | Free Full-Text | Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets
Cancers | Free Full-Text | Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy
Cancers | Free Full-Text | Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets
Obstetrics and Gynecology Clinics of North America (Update on Epithelial Ovarian Cancer, Vol. 21 No. 1 March 1994): unknown author: Amazon.com: Books
METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246 | Cell Death Discovery
Epidemiology of Ovarian Cancer | SpringerLink
Current Oncology | Free Full-Text | Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs
